Markets Gone Wild

Tarsus Pharmaceuticals’ Q4 2024 Earnings Call: Key Insights On February 25, 2025, Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) held its Year End 2024 Financial Results Conference Call. The call was led by David Nakasone, Head of Investor Relations, and featured presentations from Bobby Azamian, CEO and Chairman, Aziz Mottiwala, Chief Commercial Officer, Seshadri Neervannan, COO, and…

Phillips 66 Shares Analysis Overview Phillips 66 shares have recently underperformed due to weak refining margins in the market. However, I still hold a bullish outlook on the company’s future prospects. This is primarily due to its diversified business model and ongoing cost rationalization efforts. Midstream Segment Strength Despite facing a loss in Q4, Phillips…

Shares of NVIDIA Corp. Remain Steady After Recent Increase Breaking Down the Market Performance Shares of NVIDIA Corp. (NASDAQ: NVDA) experienced a relatively stable day of trading on Tuesday, with the stock showing a slight decrease of -0.58%. This comes after a strong performance over the past five days, during which the stock has climbed…

New Investigation Into Quantum Computing, Inc. – What Investors Need to Know Introduction As reported on February 18th, 2025, Pomerantz LLP has announced that they are currently investigating claims on behalf of investors of Quantum Computing, Inc. This investigation is focused on potential issues related to Quantum Computing’s stock on the NASDAQ under the ticker…

ServiceNow’s Disappointing Q1 Preview: A 9% Premarket Slump In the ever-evolving world of technology, investors and market observers keep a close eye on the performance of leading software and IT services providers. One such company that has recently grabbed the headlines for its disappointing financial preview is ServiceNow (NOW). Shares of ServiceNow took a nosedive…